$HYEX Healthy Extracts Launches STAT10(TM), Breakthrough

New Post Public Reply Private Reply Replies (0) Message Board
louied91
139
$HYEX Healthy Extracts Launches STAT10(TM), Breakthrough CoQ10 and Nutrient Support Formulation for America's 40 Million Statin Users

https://www.accessnewswire.com/newsroom/en/co...en-1042326

New product dramatically expands Healthy Extracts' addressable market beyond general heart health to supporting the unmet needs of millions of existing statin users.

Clinically formulated to support nutrients inhibited by statins, addressing common side effects of muscle and joint pain, weakness and tiredness.

Ingredients shown in clinical research to support heart health and the vital nutrients inhibited by statins.

LAS VEGAS, NV / ACCESS Newswire / June 24, 2025 / Healthy Extracts Inc. (OTCQB:HYEX), a leader in nutraceutical formulations and technological innovations, has launched STAT10™, a breakthrough Coenzyme Q10 (CoQ10) formulation specifically designed to support the vital nutrients inhibited by statins and thereby alleviate the common side effects of muscle and joint pain, weakness and tiredness.

"If you take a statin, our new STAT10 is a must-have addition to your daily health regime," stated Duke Pitts, president of Healthy Extracts. "STAT10 is clinically formulated to address the long unmet nutritional needs of millions of Americans who have been prescribed a statin to lower their cholesterol.

"This proprietary formulation of nutrients/ingredients is unlike any other product on the market today-it can be a life-changer for millions across the country and around the world."

The U.S. Centers for Disease Control and Prevention (CDC) reports that more than 86 million adults in the U.S. have cholesterol levels that put them at risk for heart disease.Statins have become the most prescribed medication in the country for addressing this risk, with now more than 40 million Americans taking them daily, according to Stanford Medicine.

"After many years of research and development, our official commercial launch of STAT10 marks a significant expansion into a major new market segment for Healthy Extracts," noted Pitts. "Given the vast number of statin users, combined with the deep inroads our other heart health products have made with the medical community and direct consumers, we see STAT10 driving exponential growth for Healthy Extracts."

Statins are highly effective in managing high cholesterol, resulting in them becoming the cornerstone for heart health management for millions of Americans. They are known to block an enzyme in the liver that is responsible for producing cholesterol and can help the liver remove cholesterol from the bloodstream.

But statin's mechanism-of-action also blocks or depletes essential nutrients that are critical for overall health and well-being. This includes CoQ10, a substance vital for cellular energy production and antioxidant protection.

Multiple clinical studies have demonstrated that CoQ10 plays a central role in mitochondrial oxidative phosphorylation, with several highlighting the beneficial effects of CoQ10 supplementation for cardiovascular health. The depletion of CoQ10 and other nutrients can lead to serious side effects, such as muscle pain, fatigue, and liver enzyme elevations.

STAT10 was created to effectively address these challenges and provide comprehensive nutritional support for statin users. The proprietary formulation includes these six specialized ingredients:

Unbiquinone

Omega-3s

Berberine

Bergamot BPF Gold®

Resveratrol

Vitamin C

This unique combination of ingredients is especially designed to be effective in supporting heart health. STAT10 synergizes with statins in a singular formulation at about the same price as many products which contain CoQ10 alone. It helps statin users live life to the fullest at just $69.95 for a month's supply.

The ingredients in STAT10 are highly recommended by Dr. Joel Kahn, a triple board-certified Interventional Cardiologist. Widely acclaimed as ‘America's Healthy Heart Doc,' he has appeared on Dr. Phil, Dr. Oz, Larry King Now, and The Joe Rogan Experience. He also hosts a popular video seminar, Dr. Talks, that helps people achieve their own best heart health.

"At my clinic, I encourage my patients to take these ingredients in order to naturally support the heart health nutrients that statins inhibit," explained Dr. Kahn. "The nutrients in STAT10, when taken in combination with statins, provide important synergistic benefits in just three tablets that are easy to take every day."

For the market roll out of STAT10, Healthy Extracts is using multiple platforms for educating and engaging existing and new customers, including direct-to-consumer, social media, and affiliate partnerships. The company also offers white-label options for doctors and healthcare providers who want to offer STAT10 to their statin patients.

"We expect our launch of this new product to benefit from our well-developed and diverse marketing channel which we have strategically invested in and built over many years," said Pitts. "This includes Amazon, where we have enjoyed great success and positive reviews with our other products."

The company recently reported record sales on Amazon and the achievement of a top three category ranking. Its Amazon "Subscribe & Save" customers have increased more than 81% over the past year.

STAT10 is vegan friendly, non-GMO, gluten-free with natural ingredients, and manufactured in the U.S. It is available today for purchase on trystat10.com and through affiliated healthcare providers.

To learn more about STAT10 and Healthy Extracts' other products, visit trystat10.com, bergametna.com and tryubn.com.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Atlas Power Expands with Boyland Electric Acquisition

Updated Category News Views 129

The Strategy Behind Atlas Power's Expansion Atlas Power Partners, no stranger to sizzling ambitions, has galvanized its portfolio by roping in Boyland Electric. This latest maneuver unfolds as Atlas hustles to become the go-to network for residential generator services. It’s a clear bet on 'quality over flair'—an ethos echoed by their CEO, David Fischer, who champions...

Continue Reading
Tampa General Dominates Florida Health Rankings Again

Updated Category News Views 29

Another year, another feather in the cap for Tampa General Hospital (TGH). This academic health system has grabbed the spotlight once again by securing top rankings in Newsweek's 2027 America's Best-in-State Hospitals list. You have to hand it to them; they've been the reigning champions in the Tampa Bay region every single year since these rankings kicked off. If you...

Continue Reading
Choosing Suit or Tuxedo: Insights for Weddings

Updated Category News Views 76

Decoding Wedding Attire: Suit vs. Tuxedo When it comes to wedding attire, it’s not just a simple choice between a suit or tuxedo. It’s a cascading series of choices that hinge on a myriad of factors; everything from the time of day, venue, and the level of formality to personal style tweaks can sway this decision. Listen up: Men’s clothing gurus Tom Napoli and Rico...

Continue Reading
Xi's Financial Vision: China's Path to Global Power

Updated Category News Views 59

China's Grand Financial Strategy Alright, strap in as President Xi Jinping is back on the scene painting a bold picture for China's financial future. The guy doesn't mess around when he says finance is a linchpin for the country's modernization. China's got the pedal to the metal, aiming to transform its national clout into a financial juggernaut. Key Pillars of Financial...

Continue Reading
NPK International Faces Shareholder Probe After Earnings Slide

Updated Category News Views 50

Guidance Games: From Boom to Bust in Three Months Ah, the fickle world of guidance and investor expectations. One minute, NPK International (NYSE:NPKI) was riding high on strong Q2 results, promising an optimistic Adjusted EBITDA of up to $103 million for 2026. Fast forward a few months, and we're looking at a sobering reality—a cutdown to $90 million to $93 million....

Continue Reading
Duni AB's 2027 AGM: Strategic Moves Amid Challenges

Updated Category News Views 18

Navigating Choppy Waters: Duni's Market Stance Ever have one of those days when the market just refuses to cooperate no matter how much you hustle? Duni AB knows the feeling all too well. As this Swedish outfit gears up for its 2027 AGM, they're grinding through an array of challenges as prickly as a porcupine. Here's the scoop: their interim report from earlier this year...

Continue Reading
GPN Vaccines Raises US$10M to Propel Gamma-PN Phase 2

Updated Category News Views 155

Pneumonia Vaccines Take a Bold Step GPN Vaccines is steering its course with a US$10 million private placement, aiming to shake up a traditionally complex vaccine market. This clinical-stage biotech is throwing down the gauntlet with Gamma-PN™, its lead candidate that challenges existing serotype-specific pneumococcal vaccines. The big idea? Bypass the mess of adding...

Continue Reading
Celebree's Gratitude Push: Kindness Turns into Action

Updated Category News Views 132

Expressing Gratitude: More than Just Words Gratitude: it's one of those feel-good concepts that everyone nods to, but let's face it—most folks don't really go beyond the occasional 'thanks.' That's where the Generation Gratitude Project by Celebree School steps in. The idea's not just about saying thanks, but about making it a real, action-oriented habit. This campaign,...

Continue Reading
Kim Dunbar Sheds Light on Online Personalized Learning

Updated Category News Views 71

Picture a classroom without walls, the teacher always available, and students moving at their own pace. Sounds utopian, right? Well, Virtual Public School Expert Kim Dunbar is making sense of this approach at SC Whitmore School in Columbia, South Carolina, as she explains how this works in an online high school. Mastery-Based Learning: Beyond the Conventional Rigid...

Continue Reading
MDP+ Expands to U.S. with Nordstrom Launch

Updated Category News Views 122

Picture a new player stepping onto the bustling U.S. skincare scene—Korean brand MDP+ is taking its swing at the American market through its fresh debut at Nordstrom. Now, this is more than just another cream in the aisle; it spells a strategic push into department stores, expanding the retail game's stakes for MDP+ beyond the digital shelves of Amazon and TikTok Shop....

Continue Reading

Top 5 Most Recently Viewed Articles

Vicor Launches Innovative Power Modules for Automotive Needs

Updated Category News Views 323

Vicor Introduces Groundbreaking Automotive-Grade Power Modules Vicor has recently unveiled a trio of advanced automotive-grade power modules that promise unmatched power density, fostering the widespread adoption of 48V zonal architectures in vehicles. This innovative product line includes the BCM6135, DCM3735, and PRM3735, each designed to support 48V power distribution,...

Continue Reading
NACD Board Welcomes Industry Veterans to Strengthen Governance

Updated Category News Views 226

Leadership Changes at NACD Enhance Board Effectiveness Industry veterans bring a wealth of knowledge in governance and innovation. In a landmark move, the National Association of Corporate Directors (NACD) has strengthened its board with the appointments of Jesús Mantas and Wes Bricker. Both distinguished leaders are set to enhance the governance and strategic leadership...

Continue Reading
APLA Health Unveils Significant Growth at Long Beach Center

Updated Category News Views 138

APLA Health Celebrates a New Milestone Mayor Rex Richardson and Community Leaders Join Grand Reopening Celebration APLA Health is excited to announce the grand reopening of its Long Beach Health Center, following a significant expansion aimed at improving healthcare access for the LGBTQ+ community and other underserved populations. The expanded facility is a testament to...

Continue Reading
Apnimed's AD109 Phase 3 Trial Results Highlight Game-Changer

Updated Category News Views 347

Breakthrough in Obstructive Sleep Apnea Treatment with AD109 Apnimed, a clinical-stage pharmaceutical company, has recently made headlines with positive topline results from its second Phase 3 trial of AD109, known as LunAIRo. This trial has demonstrated substantial efficacy in addressing obstructive sleep apnea (OSA), reinforcing the potential of AD109 as the first oral...

Continue Reading
Castle Biosciences Faces Stock Decline Amidst New Challenges

Updated Category News Views 215

Castle Biosciences Stock Performance Overview Castle Biosciences, Inc. (NASDAQ: CSTL) has recently seen a notable decline in its stock price, falling 14% in a single day. This drop is primarily attributed to mixed reactions to the company’s preliminary performance and the implications of a recent ruling by a key payer. Although the firm announced that it expects to meet...

Continue Reading